Sandisk Corporation · SNDK · FY2026 Q3 · Calendar Q2 2026
Sandisk Q3 Revenue Jumps 251% YoY on AI Data-Center Surge; Q4 Guidance Raised
Sandisk's Q3 FY2026 results mark a dramatic acceleration from an already strong prior quarter. Revenue of $5.95 billion (up 251% YoY) and non-GAAP EPS of $23.41 (vs. $14.62 consensus) reflect surging AI-driven data-center demand that grew 233% sequentially. Gross margin expanded to 78.4% on a higher-value customer mix. The signing of five multiyear New Business Model (NBM) agreements, backed by $11 billion in financial guarantees and covering over a third of FY27 bit volume, signals a structural shift toward contracted demand that could reduce NAND cyclicality. With Q4 guidance raised to $7.75-$8.25 billion revenue and $30-$33 EPS, plus a $6 billion buyback authorization, management is projecting sustained momentum. The stock's 8.3% post-earnings move and subsequent 48% drift suggest the market is absorbing the structural thesis, though pricing volatility and execution risk on NBM…
Company context
Snapshot as of publicationSanDisk Corporation specializes in designing, manufacturing, and supplying storage solutions and devices leveraging advanced NAND flash technology. Its diverse product line features solid-state drives (SSDs), embedded memory solutions, removable memory cards, universal serial bus (USB) devices, and underlying wafers and components. Founded on June 1, 1988, the company maintains its principal executive offices in Milpitas, California.
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Susquehanna | Positive | Positive | Maintain | Jul 23, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 22, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 1, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jun 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 25, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 8, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jun 8, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 3, 2026 |
| Barclays | Overweight | Equal Weight | Upgrade | May 27, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 1, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 1, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Apr 29, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 30, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 30, 2026 |
| Benchmark | Buy | Buy | Maintain | Jan 15, 2026 |
Named analyst price targets
Upside is calculated against the persisted current price $1,097.86. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Susquehanna | Analyst unavailable | $3,050 | $1,622.81 | +177.8% | Jul 23, 2026 |
| Susquehanna | Analyst unavailable | $3,250 | $1,599.27 | +196.0% | Jul 23, 2026 |
| Wells Fargo | Analyst unavailable | $1,620 | $1,589.4 | +47.6% | Jul 22, 2026 |
| Evercore ISI | Analyst unavailable | $3,100 | $1,915.92 | +182.4% | Jul 13, 2026 |
| Bernstein | Mark Newman | $3,000 | $2,050.39 | +173.3% | Jun 29, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $2,900 | $1,611.3 | +164.2% | Jun 8, 2026 |
| Mizuho Securities | Vijay Rakesh | $2,200 | $1,559.32 | +100.4% | Jun 8, 2026 |
| Morgan Stanley | Analyst unavailable | $1,750 | $1,737 | +59.4% | Jun 3, 2026 |
| Mizuho Securities | Vijay Rakesh | $1,825 | $1,589.94 | +66.2% | May 28, 2026 |
| Barclays | Tom O'Malley | $2,300 | $1,589.55 | +109.5% | May 26, 2026 |
| Melius Research | Analyst unavailable | $2,350 | $1,307.4 | +114.1% | May 18, 2026 |
| Mizuho Securities | Analyst unavailable | $1,625 | $1,406.32 | +48.0% | May 6, 2026 |
| UBS | Analyst unavailable | $1,700 | $1,187 | +54.8% | May 4, 2026 |
| Goldman Sachs | James Schneider | $1,200 | $1,081.43 | +9.3% | May 1, 2026 |
| Mizuho Securities | Vijay Rakesh | $1,220 | $1,148.24 | +11.1% | May 1, 2026 |
| Evercore ISI | Analyst unavailable | $1,400 | $1,141 | +27.5% | May 1, 2026 |
| Raymond James | Analyst unavailable | $1,470 | $1,142.51 | +33.9% | May 1, 2026 |
| Susquehanna | Analyst unavailable | $2,000 | $1,096.51 | +82.2% | May 1, 2026 |
| Barclays | Tom O'Malley | $1,200 | $1,096.51 | +9.3% | May 1, 2026 |
| Jefferies | Analyst unavailable | $1,400 | $1,096.51 | +27.5% | May 1, 2026 |
| Wedbush | Matt Bryson | $1,200 | $1,002.35 | +9.3% | Apr 29, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $1,400 | $989.9 | +27.5% | Apr 27, 2026 |
| Morgan Stanley | Analyst unavailable | $1,100 | $989.9 | +0.2% | Apr 27, 2026 |
| Wells Fargo | Aaron Rakers | $975 | $920.99 | -11.2% | Apr 20, 2026 |
| Evercore ISI | Analyst unavailable | $1,200 | $952.5 | +9.3% | Apr 13, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $1,000 | $851.57 | -8.9% | Apr 9, 2026 |
| Bernstein | Analyst unavailable | $1,250 | $851.57 | +13.9% | Apr 9, 2026 |
| UBS | Analyst unavailable | $1,000 | $652.79 | -8.9% | Feb 2, 2026 |
| Barclays | Tom O'Malley | $750 | $576.25 | -31.7% | Feb 2, 2026 |
| Bernstein | Analyst unavailable | $1,000 | $539.3 | -8.9% | Jan 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $800 | $539.3 | -27.1% | Jan 30, 2026 |
| Morgan Stanley | Joseph Moore | $690 | $539.3 | -37.2% | Jan 30, 2026 |
| Jefferies | Blayne Curtis | $700 | $539.3 | -36.2% | Jan 30, 2026 |
| Mizuho Securities | Analyst unavailable | $710 | $539.3 | -35.3% | Jan 30, 2026 |
| Goldman Sachs | James Schneider | $700 | $539.3 | -36.2% | Jan 30, 2026 |
| RBC Capital | Srini Pajjuri | $650 | $539.3 | -40.8% | Jan 30, 2026 |
| Raymond James | Melissa Fairbanks | $725 | $539.3 | -34.0% | Jan 30, 2026 |
| Mizuho Securities | Analyst unavailable | $600 | $470.8 | -45.3% | Jan 27, 2026 |
| Morgan Stanley | Joseph Moore | $483 | $473.83 | -56.0% | Jan 26, 2026 |
| Benchmark Co. | Analyst unavailable | $450 | $414.5 | -59.0% | Jan 15, 2026 |
| Barclays | Tom O'Malley | $385 | $387.81 | -64.9% | Jan 15, 2026 |
| Wells Fargo | Analyst unavailable | $380 | $387.81 | -65.4% | Jan 15, 2026 |
| RBC Capital | Analyst unavailable | $400 | $387.81 | -63.6% | Jan 14, 2026 |
| UBS | Analyst unavailable | $580 | $387.58 | -47.2% | Jan 14, 2026 |
| Bernstein | Analyst unavailable | $580 | $389.81 | -47.2% | Jan 14, 2026 |
| Goldman Sachs | James Schneider | $320 | $352.75 | -70.9% | Jan 9, 2026 |
| Mizuho Securities | Analyst unavailable | $410 | $334.54 | -62.7% | Jan 9, 2026 |
| Morgan Stanley | Analyst unavailable | $273 | $200.27 | -75.1% | Nov 24, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $300 | $225 | -72.7% | Nov 7, 2025 |
| UBS | Joseph Moore | $230 | $199.33 | -79.1% | Nov 3, 2025 |
| Morgan Stanley | Joseph Moore | $230 | $199.33 | -79.1% | Nov 3, 2025 |
| Wedbush | Analyst unavailable | $220 | $204.36 | -80.0% | Oct 29, 2025 |
| Mizuho Securities | Vijay Rakesh | $215 | $169.17 | -80.4% | Oct 28, 2025 |
| Mizuho Securities | Analyst unavailable | $180 | $144.27 | -83.6% | Oct 17, 2025 |
| Wells Fargo | Analyst unavailable | $115 | $116.91 | -89.5% | Oct 13, 2025 |
| Goldman Sachs | James Schneider | $55 | $46.95 | -95.0% | Jul 10, 2025 |
| Arete Research | Nam Hyung Kim | $63 | $41.82 | -94.3% | Jun 9, 2025 |
| Susquehanna | Analyst unavailable | $70 | $47.67 | -93.6% | Apr 2, 2025 |
| Wedbush | Analyst unavailable | $80 | $52.99 | -92.7% | Mar 24, 2025 |
| Mizuho Securities | Vijay Rakesh | $60 | $51 | -94.5% | Mar 10, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $60 | $51 | -94.5% | Mar 7, 2025 |
Track every rating change on SNDK the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session closeFollow SNDK with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Compared to Q2 FY2026, where revenue was $3.0 billion (up 31% sequentially) and non-GAAP EPS was $6.20, Q3 represents a step-function improvement. Revenue nearly doubled sequentially, EPS roughly quadrupled, and data-center growth accelerated from a 64% sequential gain to 233%. The prior quarter's guidance of $4.4-$4.8 billion revenue and $12-$14 EPS was exceeded by a wide margin ($5.95B actual revenue, $23.41 actual EPS). New developments this quarter include the five NBM agreements with $11 billion in financial guarantees, the $6 billion share buyback authorization, and confirmation that QLC Stargate SSDs will ship in Q4. The Kioxia JV extension previously announced in Q2 was complemented by a new Nanya investment for DRAM supply diversification. Capex outlook shifted from increasing in Q2 to stable in Q3.
Guidance delta
Q2 management guided Q3 to $4.4-$4.8 billion in revenue and $12-$14 in non-GAAP EPS. Actual Q3 results came in at $5.95 billion and $23.41, beating the midpoint of revenue guidance by approximately 24% and EPS guidance by roughly 79%. For Q4, management raised guidance to $7.75-$8.25 billion in revenue (implying 30-38% sequential growth) and $30-$33 in non-GAAP EPS, a further step-up from already elevated Q3 levels. Capex outlook shifted from increasing to stable.
Key takeaways
- Q3 revenue of $5.95 billion grew 251% YoY, with data-center revenue up 233% sequentially, driven by AI inference, KV cache, and RAG workloads.
- Non-GAAP EPS of $23.41 beat the $14.62 consensus by 60%; gross margin reached 78.4% and operating margin 70.9% on a higher-value customer mix.
- Five multiyear NBM agreements signed, backed by $11 billion in financial guarantees, covering over a third of FY27 bit volume and reducing cyclicality.
- Q4 guidance raised to $7.75-$8.25 billion revenue and $30-$33 non-GAAP EPS, implying continued sequential acceleration.
- $6 billion share buyback authorized; cash balance stands at $3.735 billion.
- QLC Stargate SSDs slated to ship in Q4, expanding the product portfolio into higher-density workloads.
Management priorities
- Ship QLC Stargate SSDs in Q4 to address higher-density workloads.
- Continue signing NBMs to increase contracted bit volume beyond a third of FY27.
- Invest in BiCS 8 roadmap and nodal transitions to sustain mid-to-high-teens bit growth.
- Extend JV with Kioxia through 2034 and expand DRAM supply via Nanya investment.
- Deploy share buybacks as cash flow permits under the $6 billion authorization.
Related earnings events
TechnologySources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-28T14:02:30.784998+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-28T14:02:30.782359+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.